Drug Database · Clinicians

Chlorpheniramine + Paracetamol + Phenylephrine

Also known as: acetaminophen (US name, for paracetamol)

Brands (10) Raphzep, Healthcare Cold & Flu Tablets, Mediflu…Show all

This entry appears to be Chlorphenamine + Paracetamol + Phenylephrine registered under a variant spelling.

See the main Chlorphenamine + Paracetamol + Phenylephrine monograph (kidney dosing, prescribing information, all brands) →

US brand (reference label): RESFRIOL D; not a Philippine-registered brand.

Analgesic/Antipyretic/Decongestant/Antihistamine; Decongestant/ antihistamine/ analgesic/ antipyretic; and others PH FDA category
Fixed-dose combination.

Rx · Prescription drugOTC · Over-the-counter13 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 0e9c96b9-41ac-0faf-e063-6294a90a8ab5, version date November 4, 2026 (RESFRIOL D · OPMX LLC). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses: temporarily relieves these symptoms of hay fever or other respiratory allergies: headache sinus congestion & pressure nasal congestion runny nose and sneezing minor aches & pain temporarily relieves these…
US FDA label
Full indications and usage US FDA label

Uses: temporarily relieves these symptoms of hay fever or other respiratory allergies: headache sinus congestion & pressure nasal congestion runny nose and sneezing minor aches & pain temporarily relieves these additional symptoms of hay fever: nose or throat itching itchy, watery eyes helps clear nasal passages helps decongest sinus opening and passages

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions: Do not take more than directed - see overdose warning Swallow whole; do not crush, chew or dissolve Do not exceed 6 tablets per 24 hours Adults and children 12 years of age & over 1 tablet with water every 4-6 hours as needed Children 4 to 12 years of age Ask a doctor Children under 4 years of age Do not use

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 2.5 mg/500 mcg/125 mg per 5 mL, 6.25 mg/0.5 mg/125 mg per 5 mL, 500 mcg/125 mg/2.5 mg per 5 mL
  • Tablet: 500 mg/10 mg/2 mg, 500 mg/25 mg/2 mg
  • Capsule: 325 mg/25 mg/2 mg
  • Film-coated tablet: 500 mg/5 mg/2 mg
  • Powder for solution: 500 mg/10 mg/4 mg

Registered products in the Philippines

13 products registered with the Food and Drug Administration (FDA) Philippines list Chlorpheniramine + Paracetamol + Phenylephrine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products13
Philippine FDA-registered products for Chlorpheniramine + Paracetamol + Phenylephrine
Package insert
Healthcare Cold & Flu TabletsParacetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate
500 mg/25 mg/2 mg TabletBlister Pack x 10's (Box of 30's)
OTC
Lloyd Laboratories, Inc.Philippines
—
DR-XY39420 (FOR EXPORT ONLY)
May 9, 2030
MedifluPhenylephrine Hydrochloride + Chlorpheniramine Maleate + Paracetamol
2.5 mg/500 mcg/125 mg per 5 mL Syrup
OTC
AZARIAS PHARMACEUTICAL LABORATORIES INC.
—
DRP-3400
Nov 22, 2026
Nagelin (Reformulated)Paracetamol + Phenylephrine HCl + Chlorpheniramine Maleate
325 mg/25 mg/2 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's)
OTC
LA CROESUS PHARMA, INC.Philippines
Trader: IAE PHARMACEUTICALS CORPORATION
DR-XY42858
Oct 23, 2028
NasalnovaParacetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate
500 mg/10 mg/2 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
OTC
Saga Lifesciences LimitedIndia
Importer: Medinova Pharmaceutical Inc.
DRP-11136
Feb 4, 2027
NasocurePhenylephrine Hydrochloride + Chlorpheniramine Maleate + Paracetamol
2.5 mg/500 mcg/125 mg per 5 mL SyrupBoston Round Amber Glasst Bottle x 60 mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
Jaac Healthline Marketing
DRP-3400-02
Nov 22, 2026
NeoflamParacetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate
500 mg/10 mg/2 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION
DRP-4461
Jun 6, 2028
NoneChlorpheniramine Maleate + Paracetamol + Phenylephrine
500 mcg/125 mg/2.5 mg per 5 mL Syrup60 mL Amber Glass Bottle (Box of 1's)
Rx
Drugmaker's Laboratories Inc.Philippines
—
DRP-7655
Mar 17, 2031
NonePhenylephrine Hydrochloride + Chlorpheniramine Maleate + Paracetamol
6.25 mg/0.5 mg/125 mg per 5 mL Syrup (Strawberry Flavor)Boston Round Amber Bottle with 20mm Plain Metal Cap x 60 mL Box of 1's
OTC
Drugmakers Laboratories Inc.Philippines
—
DRP-10287
Sep 2, 2028
RaphzepPhenylephrine Hydrochloride + Chlorpheniramine Maleate + Paracetamol
2.5mg/ 500 mcg/ 125 mg per 5 mL Syrup
OTC
AZARIAS PHARMACEUTICAL LABORATORIES INC.
ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION
DRP-3400-01
Nov 22, 2026
RaphzepParacetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate
500 mg/10 mg/2 mg TabletAlu/Clear PVC Blister Pack x 20's Box of 100's, 200's & 500's
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION
DRP-4997
Dec 9, 2028
Sinutab Cold PlusParacetamol + Phenylephrine HCl + Chlorpheniramine Maleate
500 mg/5 mg/2 mg Film-coated TabletAlu/Amber PVC Blister Pack x 20's (Box of 200's)
Rx
Probiotec Pharma Pty LimitedAustralia
JNTL Consumer Health (Philippines) Inc.
DR-XY47297
Jun 14, 2031
Sinuzip PE Forte (Lemon Flavor)Paracetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate
500 mg/10 mg/4 mg Powder for SolutionPET-Aluminum Foil-Poly Laminate Sachet x 6.1 g (Box of 50's)
OTC
Interphil Laboratories, Inc.Philippines
—
DRP-7929
Mar 8, 2028
ZynodexChlorpheniramine Maleate + Paracetamol + Phenylephrine
500mcg/125mg/2.5mg per 5mL Syrup60mL Amber glass bottle Box of 1's
OTC
Drugmaker's Laboratories Inc.Philippines
Phil Pharmawealth Inc.
DRP-7655-02
Feb 4, 2032

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take: more than 6 tablets in 24 hours, which is the maximum daily amount for this product with other drugs contains acetaminophen 3 or more alcoholic drinks every day while using this product. Allergy alert: Acetaminophen may cause severe skin reactions.

Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away. Sore throat warning: if sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult doctor promptly Do not use: with any other drug containing acetaminophen (prescription or nonprescription).

If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. if you have ever had an allergic reaction to this product or any of its ingredients to make a child sleepy Ask a doctor before use if you have: liver disease heart disease high blood pressure thyroid disease glaucoma diabetes trouble urinating due to enlarged prostate gland a breathing problem such as emphysema or chronic bronchitis Ask a doctor or pharmacist before use if you are: taking the blood thinning drug warfarin taking sedatives or tranquilizers When using this product: do not use more than directed excitability may occur, especially in children drowsiness may occur alcohol, sedatives and tranquilizers may increase drowsiness avoid alcoholic drinks be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if: nervousness, dizziness, or sleeplessness occur pain or nasal congestion gets worse or lasts more than 7 days fever gets worse or last more than 3 days redness or swelling is present new symptoms occur These could be signs of a serious condition.

If pregnant or breast-feeding: ask a health professional before use. Keep out of reach of children. Overdose warning: Taking more than directed can cause serious health problems. In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. RESFRIOL D · OPMX LLC [US FDA-approved label, version 4, November 4, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e9c96b9-41ac-0faf-e063-6294a90a8ab5
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .